Tradingview
Published September 23, 2026
NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with ...
Read the full story at Tradingview
MDMA and N-acylethanolamines for potential treatment of PTSD, anxiety and eating disorders. The continued maturation of the patent portfolio.
Surfaced by 4 Google Alerts
- MDMA
- Ketamine
- Psychedelic press release
- LSD